Osler Diagnostics Company Research Report

Company Overview

• Name: Osler Diagnostics Limited

• Mission: Enable anyone, anywhere, to access, understand, and act on their health, to live healthier, happier, and longer lives.

• Founded: 2017

• Founders: Connor Campbell collaborated with Professor Jason Davis to establish the company.

• Key People:

• Connor Campbell: Co-Founder and CEO

• Tom Parenteau: Chief Commercial Officer

• David Edington: Chief Technology Officer

• Paul Dixon: Chief Financial Officer

• David Berry: Chairman of the Board

• Roland Diggelmann, Amber Salzman, Jim Wilkinson, Andre Crawford-Brunt: Non-Executive Directors

• Headquarters: Oxford, UK

• Number of Employees: More than 100

• Revenue: No information is available

• Known For: The company is renowned for the Osler Origin®, a breakthrough portable diagnostic platform based on extensive research from Oxford University.

Products

Osler Origin®

• Description: A 'portable lab' offering lab-quality diagnostic testing capabilities globally. It consolidates multiple existing systems onto a single instrument, which is quantitative, accurate, sensitive, and multiplexed.

• Key Features:

• Comprehensive test menu capable of being used across various healthcare settings including Emergency Departments, Doctor’s Offices, Retail Pharmacies, etc.

• High-performance characteristics tailored for use anywhere, by anyone, at any time.

• Portability and low-cost operations, designed for ease of use with its three-step process: Scan, Tap, Go.

• Advanced technology powered by Osler's lab-in-your-hand technology, featuring proprietary Osler HemaTap® for sample handling and electrochemical biosensing.

Recent Developments

• Financing: On November 7th, 2022, Osler Diagnostics secured $85 million in Series C financing. This round was led by M&G Investments and included existing investors such as Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners. This investment is intended to support the advancement of the Osler Origin towards regulatory activities and market launch.

• Regulatory Progress: The completion of the Osler Origin in 2022 marked the start of regulatory activities necessary for approvals across significant regions.

• No information available: There’s no specific information on new products launched, new features added to existing products, or new partnerships other than the strategic investment noted above.

Intellectual Property

• The Osler Origin® and HemaTap® are protected by an extensive intellectual property portfolio, positioning Osler Diagnostics as a leader in the portable diagnostics space.

Conclusion

Osler Diagnostics is positioned at the forefront of the medical diagnostics industry with its innovative product, the Osler Origin®. With substantial financial backing and a team of seasoned professionals, Osler is committed to transforming global healthcare by providing accessible diagnostic solutions.